EuroIntervention | Your reference journal for coronary, valvular and structural interventions

Your reference journal for coronary, valvular and structural interventions

Editorial

Oct 9

Daniele Andreini, Carlo Di Mario

This editorial discusses how photon-counting computed tomography can provide high-resolution imaging of coronary stents, which may help guide percutaneous coronary interventions by providing detailed information to interventional cardiologists, as recent guidelines have recommended intracoronary imaging for guidance of complex PCI and PCD-CT technology is improving, which could lead to coronary CT angiography (CCTA) being equally recommended for preprocedural guidance.

free

Original Research

Oct 8

Photon-counting CT for coronary ISR

Doosup Shin, Ziad A. Ali, et al.

This study evaluated the diagnostic performance of photon-counting detector computed tomography (PCD-CT) in detecting obstructive in-stent restenosis, demonstrating good overall accuracy, sensitivity, and specificity, regardless of stent diameter.

Expert Consensus

Oct 7

Definitions and standardized endpoints for DCB use in CAD

Simone Fezzi, Patrick W. Serruys, et al.

This consensus document from the Drug Coated Balloon Academic Research Consortium aims to standardise study designs and endpoints for clinical trials involving drug-coated balloons in the treatment of obstructive coronary artery disease.

Definitions and standardized endpoints for DCB use in CAD

free

new issue

Oct 6

A new issue of EuroIntervention

Expert consensus on DCBs in CAD; photon-counting CT for ISR; clinical risk, high-risk plaques, and clinical outcomes; “double-tap” technique for BEVs; in depth analysis of the NOTION-2 trial; and more

Ahead of print

Sep 30

Rationale and design of the PROTECT IV trial

Norman Mangner, Gregg W. Stone, et al.

This content discusses the various interventions used by cardiologists to diagnose, treat, and manage cardiovascular conditions, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.

Rationale and design of the PROTECT IV trial

free

Research Correspondence

Oct 3

Redo-TAVI with ACURATE for short-frame THVs

Giuseppe Tarantini, Luca Nai Fovino, et al.

This correspondence discusses the clinical experience with the discontinued ACURATE neo2 and ACURATE Prime aortic valve systems for redo-TAVI procedures in patients with failing short-frame THVs, such as the SAPIEN 3/Ultra.

Redo-TAVI with ACURATE for short-frame THVs

Editorial

Oct 2

Post-TAVI antithrombotic therapy

Kentaro Hayashida, Juri Iwata

The study evaluated the Valve Academic Research Consortium High Bleeding Risk (VARC-HBR) criteria in TAVI patients and found the criteria were effective in stratifying bleeding risk.

free

Meet Cory, your AI Assistant!

Enhance your reading experience and get deeper insights on complex topics.

Learn more

Flashlight

Oct 6

Tricuspid valve-in-ring post-CAVI

Lluis Asmarats, Dabit Arzamendi, et al.

A 73-year-old female with prior rheumatic valve disease and tricuspid annuloplasty underwent bicaval valve implantation for massive tricuspid regurgitation, and later required a tricuspid valve-in-ring procedure due to structural valve deterioration.

Original Research

Sep 29

VARC-HBR criteria validation in anticoagulated TAVI patients

Daniël C. Overduin, Jurriën M. Ten Berg, et al.

This study evaluated the validity of the VARC-HBR criteria for predicting bleeding risk in TAVI patients. The criteria effectively identified distinct subgroups with a stepwise increase in major bleeding risk, but had moderate predictive performance for individual risk.

VARC-HBR criteria validation in anticoagulated TAVI patients

Editorial

Sep 26

Evolving optimisation targets for left main stenting

José M. de la Torre Hernandez

This study examined the use of intravascular imaging to identify minimum stent area targets that could predict outcomes after left main coronary artery stenting.

Evolving optimisation targets for left main stenting

free

Original Research

Sep 24

Optimal MSA after LM crossover stenting

Ju Hyeon Kim, Seung‐Jung Park, et al.

This study evaluated IVUS-derived segmental minimal stent area (MSA) thresholds in patients undergoing left main coronary artery (LM) to left anterior descending artery (LAD) crossover stenting. Achieving optimal stent expansion in the proximal LM and avoiding underexpansion in the distal LM and LAD ostium are critical for improving long-term outcomes.

Viewpoint

Sep 22

Early DAPT interruption

Giulio Stefanini, Raffaele De Caterina, et al.

The content discusses the guidelines for 12-month dual antiplatelet therapy as the default treatment for most patients after an acute myocardial ischemic syndrome, and presents alternatives for standard and shortened durations.

free

State-of-the-Art

Sep 19

Antithrombotic therapy in complex PCI

Domenico Simone Castiello, Raffaele Piccolo, et al.

This article discusses the optimal antithrombotic strategies for patients undergoing complex PCI, balancing ischaemic and bleeding risks, with a focus on prolonged dual antiplatelet therapy, P2Y12 inhibitor monotherapy, and dual pathway inhibition, as well as tailoring the approach for specific complex PCI scenarios.

free

Flashlight

Sep 17

Calcium burden analysis by 3DS

Nicolas Amabile, Hakim Benamer

The article describes the use of 3DStent calcium mapping technology to comprehensively evaluate the calcium burden in a calcified coronary lesion prior to percutaneous intervention, and to assess the stent deployment post-procedure, in comparison with intravascular ultrasound.